TY - JOUR
T1 - Effects of adiposity and exercise on breast tissue and systemic metabo-inflammatory factors in women at high risk or diagnosed with breast cancer
AU - Iyengar, Neil M.
AU - Zhou, Xi Kathy
AU - Mendieta, Hillary
AU - Giri, Dilip D.
AU - El-Hely, Omar
AU - Winston, Lisle
AU - Falcone, Domenick J.
AU - Wang, Hanhan
AU - Meng, Lingsong
AU - Landa, Jonathan
AU - Pollak, Michael
AU - Kirstein, Laurie
AU - Morrow, Monica
AU - Dannenberg, Andrew J.
N1 - Funding Information:
N.M. Iyengar reports grants from Breast Cancer Research Foundation, Conquer Cancer Foundation of the American Society of Clinical Oncology, NCI Core Grant, grants from Myrna and Bernard Posner during the conduct of the study; and grants from Kat’s Ribbon of Hope outside the submitted work; and personal fees from Novartis, Seattle Genetics, X. Zhou reports grants from NIH and grants from Breast Cancer Research Foundation during the conduct of the study. D.D. Giri reports grants from NCI (principal investigator, C. Thompson), Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748), and Breast Cancer Research Foundation (principal investigator, N. Iyengar) during the conduct of the study. L. Meng reports grants from NIH and Breast Cancer Research Foundation during the conduct of the study. M. Morrow reports personal fees from Roche and personal fees from Genomic Health outside the submitted work. A.J. Dannenberg reports grants from NIH/NCI, Breast Cancer Research Foundation, and grants from Botwinick-Wolfensohn Foundation during the conduct of the study. No disclosures were reported by the other authors. .
Funding Information:
This work was supported by grants, NIH/NCI U54 CA210184–01 (to A.J. Dannenberg), Conquer Cancer Foundation of the American Society of Clinical Oncology (to N.M. Iyengar), the Breast Cancer Research Foundation (to N.M Iyengar and A.J. Dannenberg), the Botwinick-Wolfensohn Foundation (in memory of Mr. and Mrs. Benjamin Botwinick; to A.J. Dannenberg), Myrna and Bernard Posner (to N.M. Iyengar), and the
Publisher Copyright:
© 2021 American Association for Cancer Research.
PY - 2021/5
Y1 - 2021/5
N2 - Excess body fat and sedentary behavior are associated with increased breast cancer risk and mortality, including in normal weight women. To investigate underlying mechanisms, we examined whether adiposity and exercise impact the breast microenvironment (e.g., inflammation and aromatase expression) and circulating metabo-inflammatory factors. In a cross-sectional cohort study, breast white adipose tissue (WAT) and blood were collected from 100 women undergoing mastectomy for breast cancer risk reduction or treatment. Self-reported exercise behavior, body composition measured by dual-energy x-ray absorptiometry (DXA), and waist:hip ratio were obtained prior to surgery. Breast WAT inflammation (B-WATi) was assessed by IHC and aromatase expression was assessed by quantitative PCR. Metabolic and inflammatory blood biomarkers that are predictive of breast cancer risk and progression were measured. B-WATi was present in 56 of 100 patients and was associated with older age, elevated BMI, postmenopausal status, decreased exercise, hypertension and dyslipidemia (Ps < 0.001). Total body fat and trunk fat correlated with B-WATi and breast aromatase levels (Ps < 0.001). Circulating C-reactive protein, IL6, insulin, and leptin positively correlated with body fat and breast aromatase levels, while negative correlations were observed for adiponectin and sex hormone binding globulin (P < 0.001). Inverse relationships were observed with exercise (Ps < 0.05). In a subgroup of 39 women with normal BMI, body fat levels positively correlated with B-WATi and aromatase expression (Ps < 0.05). In conclusion, elevated body fat levels and decreased exercise are associated with protumorigenic micro- and host environments in normal, overweight, and obese individuals. These findings support the development of BMI-agnostic lifestyle interventions that target adiposity.
AB - Excess body fat and sedentary behavior are associated with increased breast cancer risk and mortality, including in normal weight women. To investigate underlying mechanisms, we examined whether adiposity and exercise impact the breast microenvironment (e.g., inflammation and aromatase expression) and circulating metabo-inflammatory factors. In a cross-sectional cohort study, breast white adipose tissue (WAT) and blood were collected from 100 women undergoing mastectomy for breast cancer risk reduction or treatment. Self-reported exercise behavior, body composition measured by dual-energy x-ray absorptiometry (DXA), and waist:hip ratio were obtained prior to surgery. Breast WAT inflammation (B-WATi) was assessed by IHC and aromatase expression was assessed by quantitative PCR. Metabolic and inflammatory blood biomarkers that are predictive of breast cancer risk and progression were measured. B-WATi was present in 56 of 100 patients and was associated with older age, elevated BMI, postmenopausal status, decreased exercise, hypertension and dyslipidemia (Ps < 0.001). Total body fat and trunk fat correlated with B-WATi and breast aromatase levels (Ps < 0.001). Circulating C-reactive protein, IL6, insulin, and leptin positively correlated with body fat and breast aromatase levels, while negative correlations were observed for adiponectin and sex hormone binding globulin (P < 0.001). Inverse relationships were observed with exercise (Ps < 0.05). In a subgroup of 39 women with normal BMI, body fat levels positively correlated with B-WATi and aromatase expression (Ps < 0.05). In conclusion, elevated body fat levels and decreased exercise are associated with protumorigenic micro- and host environments in normal, overweight, and obese individuals. These findings support the development of BMI-agnostic lifestyle interventions that target adiposity.
UR - http://www.scopus.com/inward/record.url?scp=85105333501&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105333501&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-20-0507
DO - 10.1158/1940-6207.CAPR-20-0507
M3 - Article
C2 - 33648942
AN - SCOPUS:85105333501
SN - 1940-6207
VL - 14
SP - 541
EP - 550
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 5
ER -